Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2021

Jan 21, 2022

SELL
$12.09 - $14.68 $203,353 - $246,917
-16,820 Closed
0 $0
Q3 2021

Nov 12, 2021

SELL
$13.25 - $15.13 $13,448 - $15,356
-1,015 Reduced 5.69%
16,820 $228,000
Q2 2021

Aug 03, 2021

BUY
$12.97 - $16.15 $3,929 - $4,893
303 Added 1.73%
17,835 $255,000
Q1 2021

May 20, 2021

BUY
$13.59 - $18.54 $13,685 - $18,669
1,007 Added 6.09%
17,532 $245,000
Q4 2020

Mar 09, 2021

BUY
$14.3 - $18.74 $236,307 - $309,678
16,525 New
16,525 $309,000

Others Institutions Holding VTRS

About Viatris Inc


  • Ticker VTRS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 1,212,669,952
  • Market Cap $13.5B
  • Description
  • Viatris Inc. operates as a healthcare company worldwide. The company operates in four segments: Developed Markets, Greater China, JANZ, and Emerging Markets. It offers prescription brand drugs, generic drugs, complex generic drugs, biosimilars, and active pharmaceutical ingredients (APIs). The company offers drugs in various therapeutic areas, i...
More about VTRS
Track This Portfolio

Track Tru Independence LLC Portfolio

Follow Tru Independence LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Tru Independence LLC, based on Form 13F filings with the SEC.

News

Stay updated on Tru Independence LLC with notifications on news.